Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $39.9500 (-1.53%) ($38.7900 - $41.6400) on Sat. Dec. 1, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.86% (three month average) | RSI | 60 | Latest Price | $39.9500(-1.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.9% a day on average for past five trading days. | Weekly Trend | ATRA advances 6.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting ATRA price | ATRA will decline at least -1.93% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.93% (StdDev 3.86%) | Hourly BBV | 0 () | Intraday Trend | -1% | | | |
|
5 Day Moving Average | $39.42(1.34%) | 10 Day Moving Average | $38.28(4.36%) | 20 Day Moving Average | $37.23(7.31%) | To recent high | -8.2% | To recent low | 26.4% | Market Cap | $N/A | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |